146 related articles for article (PubMed ID: 19852742)
21. Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.
Keutgen XM; Filicori F; Fahey TJ
Expert Rev Mol Diagn; 2013 Jul; 13(6):613-23. PubMed ID: 23895130
[TBL] [Abstract][Full Text] [Related]
22. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
[TBL] [Abstract][Full Text] [Related]
23. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Ann Surg; 2005 Sep; 242(3):353-61; discussion 361-3. PubMed ID: 16135921
[TBL] [Abstract][Full Text] [Related]
24. Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?
Faquin WC
Cancer Cytopathol; 2013 Mar; 121(3):116-9. PubMed ID: 23364882
[TBL] [Abstract][Full Text] [Related]
25. Recent developments in predicting thyroid malignancy.
Stang MT; Carty SE
Curr Opin Oncol; 2009 Jan; 21(1):11-7. PubMed ID: 19125013
[TBL] [Abstract][Full Text] [Related]
26. Molecular markers in thyroid cancer diagnostics.
Kato MA; Fahey TJ
Surg Clin North Am; 2009 Oct; 89(5):1139-55. PubMed ID: 19836489
[TBL] [Abstract][Full Text] [Related]
27. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
29. Molecular classification and biomarker discovery in papillary thyroid carcinoma.
Sheils O
Expert Rev Mol Diagn; 2005 Nov; 5(6):927-46. PubMed ID: 16255634
[TBL] [Abstract][Full Text] [Related]
30. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
[TBL] [Abstract][Full Text] [Related]
31. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
32. BRAF mutation in thyroid cancer.
Xing M
Endocr Relat Cancer; 2005 Jun; 12(2):245-62. PubMed ID: 15947100
[TBL] [Abstract][Full Text] [Related]
33. Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.
Penna GC; Vaisman F; Vaisman M; Sobrinho-Simões M; Soares P
Cytogenet Genome Res; 2016; 150(3-4):194-207. PubMed ID: 28231576
[TBL] [Abstract][Full Text] [Related]
34. Perspectives for improved and more accurate classification of thyroid epithelial tumors.
Eszlinger M; Krohn K; Hauptmann S; Dralle H; Giordano TJ; Paschke R
J Clin Endocrinol Metab; 2008 Sep; 93(9):3286-94. PubMed ID: 18593772
[TBL] [Abstract][Full Text] [Related]
35. Molecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules.
Fallahi P; Giannini R; Miccoli P; Antonelli A; Basolo F
Curr Genomics; 2014 Jun; 15(3):171-7. PubMed ID: 24955024
[TBL] [Abstract][Full Text] [Related]
36. Molecular markers in well-differentiated thyroid cancer.
D'Cruz AK; Vaish R; Vaidya A; Nixon IJ; Williams MD; Vander Poorten V; López F; Angelos P; Shaha AR; Khafif A; Skalova A; Rinaldo A; Hunt JL; Ferlito A
Eur Arch Otorhinolaryngol; 2018 Jun; 275(6):1375-1384. PubMed ID: 29626249
[TBL] [Abstract][Full Text] [Related]
37. Molecular approaches to thyroid cancer diagnosis.
Hsiao SJ; Nikiforov YE
Endocr Relat Cancer; 2014 Oct; 21(5):T301-13. PubMed ID: 24829266
[TBL] [Abstract][Full Text] [Related]
38. The value of miRNA in diagnosing thyroid cancer: a systematic review.
Lodewijk L; Prins AM; Kist JW; Valk GD; Kranenburg O; Rinkes IH; Vriens MR
Cancer Biomark; 2012; 11(6):229-38. PubMed ID: 23248180
[TBL] [Abstract][Full Text] [Related]
39. Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.
Yip L
J Surg Oncol; 2015 Jan; 111(1):43-50. PubMed ID: 25155423
[TBL] [Abstract][Full Text] [Related]
40. A robust biomarker of differential correlations improves the diagnosis of cytologically indeterminate thyroid cancers.
Gomez-Rueda H; Palacios-Corona R; Gutiérrez-Hermosillo H; Trevino V
Int J Mol Med; 2016 May; 37(5):1355-62. PubMed ID: 27035928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
